Local Coverage DeterminationOrthopedics

LCD L38201: Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF) — CGS

LCD-L38201

Document details

Document type
Local Coverage Determination
Issuing body
MAC Contractor
Document ID
LCD-L38201
Published
June 5, 2026
Effective date
November 20, 2025
MAC region
CGS Administrators

Summary

The new LCD for Percutaneous Vertebral Augmentation (PVA) is set to impact reimbursement for vertebral compression fractures starting 11/20/2025. Providers should prepare for potential changes in cove

New PVA LCD impacts billing starting 11/20/2025.

Affected codes

ICD-10-CM

Affected specialty

Orthopedics alerts →

Source document

https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=38201&ver=25

CLV Intelligence summarizes publicly available federal publications. Not affiliated with or endorsed by any government agency.

Related alerts

4

Proposed LCD DL33318: Knee Orthoses — CGS

Policy LCD-DL33318 · Orthopedics

High

The proposed Local Coverage Determination (LCD) for Knee Orthoses may have significant implications on billing for orthopedic practices. If implemented, providers may need to adjust their claims submi

View alert

Proposed LCD DL40232: Total Joint Arthroplasty — CGS

Policy LCD-DL40232 · Orthopedics

High

The proposed LCD for Total Joint Arthroplasty may impact the coverage and reimbursement rates for providers performing this procedure. Ensuring compliance with new guidelines and requisite documentati

View alert

LCD L39068: Platelet Rich Plasma — Novitas

Policy LCD-L39068 · Orthopedics

High

The implementation of the LCD for Platelet Rich Plasma (PRP) by Novitas may impact billing practices for providers offering this treatment. Facilities and providers need to ensure compliance with the

View alert

LCD L39071: Platelet Rich Plasma — First Coast

Policy LCD-L39071 · Orthopedics

High

The introduction of the LCD for Platelet Rich Plasma by First Coast may significantly affect billing practices for providers utilizing this treatment. Understanding the effective date and coverage spe

View alert